Combinatorial patterns of somatic gene mutations in cancer
- 19 March 2008
- journal article
- review article
- Published by Wiley in The FASEB Journal
- Vol. 22 (8) , 2605-2622
- https://doi.org/10.1096/fj.08-108985
Abstract
Cancer is a complex process in which the abnormalities of many genes appear to be involved. The combinatorial patterns of gene mutations may reveal the functional relations between genes and pathways in tumorigenesis as well as identify targets for treatment. We examined the patterns of somatic mutations of cancers from Catalog of Somatic Mutations in Cancer (COSMIC), a large-scale database curated by the Wellcome Trust Sanger Institute. The frequently mutated genes are well-known oncogenes and tumor suppressors that are involved in generic processes of cell-cycle control, signal transduction, and stress responses. These “signatures” of gene mutations are heterogeneous when the cancers from different tissues are compared. Mutations in genes functioning in different pathways can occur in the same cancer (i.e., co-occur), whereas those in genes functioning in the same pathway are rarely mutated in the same sample. This observation supports the view of tumorigenesis as derived from a process like Darwinian e...Keywords
This publication has 43 references indexed in Scilit:
- Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsProceedings of the National Academy of Sciences, 2006
- COSMIC 2005British Journal of Cancer, 2006
- Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinomaBritish Journal of Cancer, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on PrognosisJournal of Clinical Oncology, 2003
- Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor functionOncogene, 2000
- Stabilization of β-Catenin by Genetic Defects in Melanoma Cell LinesScience, 1997
- Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cellsCell, 1993
- Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital developmentNature Genetics, 1992
- A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populationsCell, 1991